Drug shortage
Hydroxychloroquine Sulfate Tablet · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Jan 5, 2026
Key facts
| Generic name | Hydroxychloroquine Sulfate Tablet |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Anti-Infective Other Rheumatology |
| Package NDCs | 0093-2401-01 |
| First posted | Jan 5, 2026 |
| Last updated | Jan 5, 2026 |
| Discontinued | Jan 5, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: